Invion and Hovione Partner to Develop Inhaled Zafirlukast for Asthma – Lung Disease News


Lung Disease News

Invion and Hovione Partner to Develop Inhaled Zafirlukast for Asthma
Lung Disease News
Australia-based pharmaceutical company Invion Ltd. recently signed a partnership agreement with Hovione Scientia Ltd., a multinational pharmaceutical company focused on developing inhaled therapeutics, for the advancement of INV104 (zafirlukast) as a …

and more »

View full post on asthma – Google News

Invion and Hovione Partner to Develop Inhaled Zafirlukast for Asthma Lung … – Lung Disease News

Invion and Hovione Partner to Develop Inhaled Zafirlukast for Asthma Lung
Lung Disease News
GSK Expands Its COPD And Asthma Portfolio Across The US. Australia-based pharmaceutical company Invion Ltd. recently signed a partnership agreement with Hovione Scientia Ltd., a multinational pharmaceutical company focused on developing inhaled …

View full post on asthma – Google News